Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis
- 590 Downloads
To conduct a systematic review and meta-analysis of published evidence on ethnic or racial disparities in the outpatient use versus non-use of antipsychotics and in the outpatient use of newer versus older antipsychotics.
Electronic databases were searched for potentially relevant studies. Two independent reviewers conducted the review in three stages: title review, abstract review and full-text review. Included studies were those that: (a) report measures of disparity in the outpatient use of antipsychotic drugs in clearly defined racial or ethnic groups (b) have a primary focus on ethnic or racial disparities, and (c) have adjusted for factors known to influence medicine use. Odds ratios were pooled following the inverse-variance method of weighting effect sizes. I 2 statistics were calculated to quantify the amount of variation that is likely due to heterogeneity between studies. Funnel plots were produced and Egger’s statistic was calculated to assess potential publication bias.
No significant differences were found in the odds of using any antipsychotics among African Americans (OR = 1.01, CI = 0.99–1.02) compared with non-African Americans and among Latinos (OR = 0.98, CI = 0.86–1.13) compared with non-Latinos. Small to moderate but statistically non-significant disparities were also noted in other ethnic groups: Asians (OR = 1.10, CI = 0.88–1.36), Maoris (OR = 0.78, CI = 0.53–1.13) and Pacific Islanders (OR = 0.97, CI = 0.84–1.11). Among those who received antipsychotic medication, African Americans (OR = 0.62, CI = 0.50–0.78) and Latinos (OR = 0.77, CI = 0.73–0.81) appeared to have lower odds of receiving newer antipsychotics compared with non-African Americans and non-Latinos.
No significant ethnic disparities in the use versus non-use of any antipsychotics were observed, but, among those who received antipsychotic treatment, ethnic minorities were consistently less likely than non-ethnic minorities to be treated with newer antipsychotics.
KeywordsRacial Ethnic Disparities Antipsychotics Schizophrenia
Conflict of interest
The authors report no competing interests.
- 1.Association AP (2000) Diagnostic and statistical manual of mental disorders DSM-IV-TR, 4th edn. American Psychiatric Publication, WashingtonGoogle Scholar
- 10.Smedley BD, Stith AY, Nelson AR (2003) Unequal treatment: confronting racial and ethnic disparities in health care. National Academy Press, WashingtonGoogle Scholar
- 11.Andersen R, Newman JF (2005) Societal and individual determinants of medical care utilization in the United States. Milbank Q 83(4):1–24Google Scholar
- 15.StataCorp (2007) Stata statistical software: Release 10. StataCorp LP, College StationGoogle Scholar
- 28.Canadian Psychiatric Association (2005) Clinical practice guidelines: treatment of schizophrenia. Can J Psychiatry 50(13 Suppl 1):7S–57SGoogle Scholar
- 29.American Psychiatric Association (2004) APA practice guidelines for the treatment of psychiatric disorders: comprehensive guidelines and guideline watches [Internet], 2nd edn. American Psychiatric Association, Arlington; [cited 2010 Mar 30]. http://www.psychiatryonline.com/pracGuide/pracguideChapToc_6.aspx
- 30.Hargraves JL (2004) Trends in health insurance coverage and access among black, Latino and white Americans, 2001–2003. Center for Studying Health System Change, WashingtonGoogle Scholar
- 32.Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, Hazuda HP (2003) All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study-evidence against the “Hispanic paradox”. Am J Epidemiol 158(11):1048–1057PubMedCrossRefGoogle Scholar
- 33.Henderson DC (2005) Metabolic differences of antipsychotics among the races. CNS Spectr 10(3 Suppl 2):13–20Google Scholar